Antibody Solutions, a leading provider of fit-for-purpose antibody discovery services, announced today that for the first ...

a leading provider of fit-for-purpose antibody discovery services, announced today that for the first time, single plasma B-cell discovery services will be part of the company’s exclusive ...

Bruker Corporation today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

Researchers at MIT have developed a noninvasive medical monitoring device powerful enough to detect single cells within blood ...

Natural Grocers®, the leading family-operated organic and natural grocery retailer in the U.S., invites Nebraska customers to ...

In part 4 of an interview with The American Journal of Managed Care®, Frederick L. Locke, MD, provides insight on the design ...

Researchers at MIT have developed a noninvasive medical monitoring device powerful enough to detect single cells within blood ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Northwestern University spinout Grove Biopharma, a synthetic biology specialist developing a platform known as Bionic ...

paired with high-throughput single B cell phenotypic screening and mining of next-generation sequencing datasets with custom algorithms, is used to identify fully-human antibodies with exceptional ...